You are here

  • Home
  • Archive
  • Volume 12, Issue 2
  • Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: February 2024 to November 2024

AbstractFullPdf
Feb 202412931310456
Mar 2024347348223
Apr 2024422425181
May 2024216225129
Jun 2024233235110
Jul 2024265274110
Aug 202416816999
Sep 202418618999
Oct 202419920189
Nov 2024232234114
Total356136101610